Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Stryker Corp., long-term (investment) activity ratios (quarterly data)
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Stryker Corp. net fixed asset turnover ratio deteriorated from Q3 2021 to Q4 2021 but then improved from Q4 2021 to Q1 2022 exceeding Q3 2021 level. |
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Stryker Corp. total asset turnover ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Stryker Corp. equity turnover ratio deteriorated from Q3 2021 to Q4 2021 but then slightly improved from Q4 2021 to Q1 2022. |
Net Fixed Asset Turnover
Stryker Corp., net fixed asset turnover calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Net sales | 4,275) | 4,701) | 4,160) | 4,294) | 3,953) | 4,262) | 3,737) | 2,764) | 3,588) | 4,131) | 3,587) | 3,650) | 3,516) | 3,796) | 3,242) | 3,322) | 3,241) | 3,471) | 3,006) | 3,012) | 2,955) | |||||||
| Property, plant and equipment, net | 2,793) | 2,833) | 2,746) | 2,738) | 2,710) | 2,752) | 2,529) | 2,527) | 2,607) | 2,567) | 2,460) | 2,387) | 2,297) | 2,291) | 2,178) | 2,101) | 2,054) | 1,975) | 1,852) | 1,758) | 1,655) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||
| Net fixed asset turnover1 | 6.24 | 6.04 | 6.07 | 5.93 | 5.43 | 5.21 | 5.62 | 5.57 | 5.74 | 5.80 | 5.91 | 5.95 | 6.04 | 5.94 | 6.10 | 6.21 | 6.20 | 6.30 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Net Fixed Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | 5.00 | 4.81 | 4.79 | 4.56 | 4.23 | 3.83 | 3.74 | 3.77 | 4.06 | 3.97 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | 47.95 | 46.73 | 41.42 | 40.56 | 39.29 | 37.85 | 37.05 | 36.02 | 35.37 | 34.45 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 23.26 | 22.56 | 22.24 | 21.90 | 21.42 | 21.25 | 21.48 | 21.52 | 21.49 | 21.24 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 35.81 | 34.94 | 34.54 | 34.17 | 34.94 | 34.69 | 34.61 | 32.74 | 32.30 | 32.92 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 27.05 | 26.97 | 27.83 | 29.47 | 31.04 | 32.05 | 32.90 | 33.07 | 33.20 | 32.93 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 3.00 | 3.04 | 3.16 | 3.13 | 2.86 | 2.76 | 2.85 | 3.00 | 3.36 | 3.52 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 6.12 | 5.77 | 5.56 | 5.64 | 5.72 | 5.99 | 6.52 | 6.50 | 6.51 | 6.54 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 32.16 | 31.81 | 31.77 | 30.94 | 30.76 | 29.64 | 30.80 | 30.30 | 29.91 | 27.60 | — | — | — | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Net fixed asset turnover
= (Net salesQ1 2022
+ Net salesQ4 2021
+ Net salesQ3 2021
+ Net salesQ2 2021)
÷ Property, plant and equipment, net
= (4,275 + 4,701 + 4,160 + 4,294)
÷ 2,793 = 6.24
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Stryker Corp. net fixed asset turnover ratio deteriorated from Q3 2021 to Q4 2021 but then improved from Q4 2021 to Q1 2022 exceeding Q3 2021 level. |
Total Asset Turnover
Stryker Corp., total asset turnover calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Net sales | 4,275) | 4,701) | 4,160) | 4,294) | 3,953) | 4,262) | 3,737) | 2,764) | 3,588) | 4,131) | 3,587) | 3,650) | 3,516) | 3,796) | 3,242) | 3,322) | 3,241) | 3,471) | 3,006) | 3,012) | 2,955) | |||||||
| Total assets | 36,137) | 34,631) | 34,145) | 33,698) | 33,455) | 34,330) | 32,286) | 31,483) | 29,440) | 30,167) | 26,659) | 26,354) | 25,937) | 27,229) | 22,084) | 21,570) | 22,133) | 22,197) | 21,485) | 21,292) | 20,517) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||
| Total asset turnover1 | 0.48 | 0.49 | 0.49 | 0.48 | 0.44 | 0.42 | 0.44 | 0.45 | 0.51 | 0.49 | 0.55 | 0.54 | 0.53 | 0.50 | 0.60 | 0.60 | 0.58 | 0.56 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Total Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | 0.60 | 0.57 | 0.57 | 0.55 | 0.51 | 0.48 | 0.47 | 0.46 | 0.48 | 0.47 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | 1.15 | 1.11 | 1.09 | 1.07 | 1.06 | 1.02 | 0.97 | 0.96 | 0.99 | 0.98 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 1.28 | 1.25 | 1.21 | 1.20 | 1.18 | 1.16 | 1.14 | 1.12 | 1.13 | 1.15 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 1.42 | 1.41 | 1.35 | 1.33 | 1.29 | 1.39 | 1.34 | 1.28 | 1.31 | 1.33 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 1.86 | 1.87 | 1.78 | 2.08 | 2.08 | 2.17 | 1.90 | 1.82 | 1.94 | 2.21 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 0.43 | 0.42 | 0.42 | 0.42 | 0.39 | 0.39 | 0.41 | 0.43 | 0.47 | 0.46 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 0.34 | 0.32 | 0.29 | 0.29 | 0.30 | 0.32 | 0.33 | 0.34 | 0.34 | 0.34 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 1.33 | 1.34 | 1.30 | 1.29 | 1.27 | 1.30 | 1.31 | 1.28 | 1.29 | 1.38 | — | — | — | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Total asset turnover
= (Net salesQ1 2022
+ Net salesQ4 2021
+ Net salesQ3 2021
+ Net salesQ2 2021)
÷ Total assets
= (4,275 + 4,701 + 4,160 + 4,294)
÷ 36,137 = 0.48
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Stryker Corp. total asset turnover ratio improved from Q3 2021 to Q4 2021 but then deteriorated significantly from Q4 2021 to Q1 2022. |
Equity Turnover
Stryker Corp., equity turnover calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Net sales | 4,275) | 4,701) | 4,160) | 4,294) | 3,953) | 4,262) | 3,737) | 2,764) | 3,588) | 4,131) | 3,587) | 3,650) | 3,516) | 3,796) | 3,242) | 3,322) | 3,241) | 3,471) | 3,006) | 3,012) | 2,955) | |||||||
| Total Stryker shareholders’ equity | 15,046) | 14,877) | 14,178) | 13,820) | 13,502) | 13,084) | 12,986) | 12,754) | 13,115) | 12,807) | 12,315) | 11,943) | 11,693) | 11,730) | 9,860) | 9,460) | 9,214) | 9,966) | 10,425) | 10,035) | 9,704) | |||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||
| Equity turnover1 | 1.16 | 1.15 | 1.18 | 1.18 | 1.09 | 1.10 | 1.10 | 1.10 | 1.14 | 1.16 | 1.18 | 1.19 | 1.19 | 1.16 | 1.35 | 1.38 | 1.38 | 1.25 | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Equity Turnover, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | 1.26 | 1.20 | 1.23 | 1.19 | 1.11 | 1.06 | 1.03 | 1.03 | 1.06 | 1.03 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | 3.81 | 3.66 | 3.56 | 3.40 | 3.36 | 3.16 | 3.24 | 3.24 | 3.39 | 3.36 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | 4.05 | 3.87 | 3.82 | 3.79 | 3.81 | 3.86 | 3.86 | 3.87 | 4.01 | 4.00 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | 3.97 | 3.80 | 3.71 | 3.65 | 3.65 | 3.64 | 3.43 | 3.26 | 3.41 | 3.25 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | 5.63 | 5.15 | 4.96 | 5.34 | 5.48 | 5.54 | 4.65 | 4.86 | 5.44 | 5.35 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | 0.49 | 0.48 | 0.48 | 0.48 | 0.45 | 0.45 | 0.47 | 0.50 | 0.54 | 0.54 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 0.61 | 0.59 | 0.55 | 0.56 | 0.56 | 0.57 | 0.60 | 0.61 | 0.61 | 0.61 | — | — | — | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | 4.06 | 3.98 | 3.95 | 3.92 | 3.94 | 3.90 | 3.85 | 3.87 | 4.29 | 4.17 | — | — | — | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
1 Q1 2022 Calculation
Equity turnover
= (Net salesQ1 2022
+ Net salesQ4 2021
+ Net salesQ3 2021
+ Net salesQ2 2021)
÷ Total Stryker shareholders’ equity
= (4,275 + 4,701 + 4,160 + 4,294)
÷ 15,046 = 1.16
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Stryker Corp. equity turnover ratio deteriorated from Q3 2021 to Q4 2021 but then slightly improved from Q4 2021 to Q1 2022. |